Who
William Lis
Director
Company insider
Files Form 4 as: Director, Zai Lab; Director and Officer, Jasper Therapeutics; Director, Eidos Therapeutics; Chief Executive Officer, Portola Pharmaceuticals.
In numbers
- Trades disclosed
- 154
- Buys
- 0
- Sells
- 39
- Bought
- $0
- Sold
- $29.2M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 26 Mar 2014
- Last trade
- 12 Aug 2026
- Last filed
- 13 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 13 Aug 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $213K8,506 at $25.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $213K8,506 at $25.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $127K7,040 at $18.09 | filing |
| 22 Jun 2026filed 24 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $127K7,040 at $18.09 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —22,371 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —22,371 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $493K13,814 at $35.67 | filing |
| 18 Jun 2025filed 23 Jun 2025 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —10,831 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $495K15,000 at $32.98 | filing |
| 1 Jul 2024filed 3 Jul 2024 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $178K10,297 at $17.31 | filing |
| 1 Jul 2024filed 3 Jul 2024 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $1,804100 at $18.04 | filing |
| 18 Jun 2024filed 20 Jun 2024 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —21,253 at $0.00 | filing |
| 13 Oct 2023filed 13 Oct 2023 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,7707,965 at $0.85 | filing |
| 29 Jun 2023filed 30 Jun 2023 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | $500K18,903 at $26.45 | filing |
| 7 Jun 2023filed 8 Jun 2023 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 13 Apr 2023filed 14 Apr 2023 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Sold | $12K8,500 at $1.44 | filing |
| 3 Mar 2023filed 7 Mar 2023 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $208K5,434 at $38.31 | filing |
| 12 Oct 2022filed 13 Oct 2022 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 27 Jun 2022filed 28 Jun 2022 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Sold | $51K24,743 at $2.08 | filing |
| 24 Jun 2022filed 28 Jun 2022 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K24,743 at $2.02 | filing |
News
Head-To-Head Contrast: Zai Lab (NASDAQ:ZLAB) versus Madrigal Pharmaceuticals (NASDAQ:MDGL)ZLAB · dailypolitical.com · 25 Oct 2026
0 headlines in the last 90 days name William Lis; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.